Carlos
Roncero Alonso
Profesor Titular de Universidad
Universitat Autònoma de Barcelona
Barcelona, EspañaPublicaciones en colaboración con investigadores/as de Universitat Autònoma de Barcelona (114)
2023
2022
-
A Feasibility Study of Patients with Major Depression and Substance Use Disorders: Vortioxetine as Maintenance Treatment
Neuropsychiatric Disease and Treatment, Vol. 18, pp. 965-976
-
The challenge of community mental health interventions with patients, relatives, and health professionals during the COVID-19 pandemic: a real-world 9-month follow-up study
Scientific Reports, Vol. 12, Núm. 1
2021
-
Alexithymia in Patients With Substance Use Disorders and Its Relationship With Psychiatric Comorbidities and Health-Related Quality of Life
Frontiers in Psychiatry, Vol. 12
-
Is alexithymia related to retention and relapses in patients with substance use disorders?: A one year follow-up study
Addictive Behaviors, Vol. 113
-
Psychiatric Comorbidity and Addiction Severity Differences in Patients With ADHD Seeking Treatment for Cannabis or Cocaine Use Disorders
Journal of Attention Disorders, Vol. 25, Núm. 7, pp. 978-988
-
Psychosis induced by abuse of ayahuasca: a case report
Revista Colombiana de Psiquiatria, Vol. 50, Núm. 1, pp. 43-46
-
Treatment retention and abstinence of patients with substance use disorders according to addiction severity and psychiatry comorbidity: A six-month follow-up study in an outpatient unit
Addictive Behaviors, Vol. 117
-
Validation of the Opioid Overdose Knowledge (OOKS) and Attitudes (OOAS) Scales in French, Spanish, and German Languages, among a Sample of Opioid Users
European Addiction Research, Vol. 27, Núm. 5, pp. 326-331
2020
-
Benzodiazepine abuse, misuse, dependence, and withdrawal among schizophrenic patients: A review of the literature
Psychiatry Research, Vol. 284
-
Cannabis use during pregnancy and its relationship with fetal developmental outcomes and psychiatric disorders. A systematic review
Reproductive Health, Vol. 17, Núm. 1
-
Correlation between disease severity factors and EQ-5D utilities in chronic obstructive pulmonary disease
Quality of Life Research, Vol. 29, Núm. 3, pp. 607-617
-
Corrigendum to “Evaluation of previous substance dependence genome-wide significant findings in a Spanish sample” (Drug and Alcohol Dependence (2018) 187 (358–362), (S0376871618302096), (10.1016/j.drugalcdep.2018.03.013))
Drug and Alcohol Dependence
-
Insomnia Symptoms in Patients With Substance Use Disorders During Detoxification and Associated Clinical Features
Frontiers in Psychiatry, Vol. 11
-
Professional perception of clozapine use in patients with dual psychosis
Actas Espanolas de Psiquiatria, Vol. 48, Núm. 3, pp. 99-105
2019
-
ADGRL3 (LPHN3) variants predict substance use disorder
Translational Psychiatry, Vol. 9, Núm. 1
-
Difficulties in initiating hepatitis C treatment in patients with opioid usdisorder: Patient's perspective
Heroin Addiction and Related Clinical Problems, Vol. 21, Núm. 3, pp. 47-51
-
Mood disorders and severity of addiction in alcohol-dependent patients could be mediated by sex differences
Frontiers in Psychiatry, Vol. 10, Núm. MAY
-
Practical steps to improve chronic hepatitis C treatment in people with opioid use disorder
HEPATIC MEDICINE-EVIDENCE AND RESEARCH, Vol. 11, pp. 1-10
-
Psychiatric Comorbidity in Treatment-Seeking Alcohol Dependence Patients With and Without ADHD
Journal of Attention Disorders, Vol. 23, Núm. 12, pp. 1497-1504